Screener
Thermo Fisher Scientific TMO Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Thermo Fisher Scientific in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000097745-26-000092
| (In millions except share and per share amounts) | March 28, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Short-term obligations and current maturities of long-term obligations | $3,090 | $3,533 |
| Accounts payable | 3,344 | 3,622 |
| Accrued payroll and employee benefits | 1,565 | 1,995 |
| Contract liabilities | 2,928 | 2,710 |
| Other accrued expenses | 3,694 | 3,329 |
| Total current liabilities | 14,621 | 15,189 |
| Deferred income taxes | 2,107 | 1,493 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Thermo Fisher Scientific's accrued manufacturing costs?
- Thermo Fisher Scientific (TMO) reported accrued manufacturing costs of $1.57B in Q1 2026.
- How has Thermo Fisher Scientific's accrued manufacturing costs changed year-over-year?
- Thermo Fisher Scientific's accrued manufacturing costs increased by 10.3% year-over-year, from $1.42B to $1.57B.
- What is the long-term trend for Thermo Fisher Scientific's accrued manufacturing costs?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's accrued manufacturing costs has grown at a 0.8% compound annual growth rate (CAGR), from $1.92B to $2B.
Ask your AI about Thermo Fisher Scientific's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude